United States - English - NLM (National Library of Medicine)

greenstone llc - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg - rifabutin capsules are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. rifabutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

United States - English - NLM (National Library of Medicine)

american health packaging - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg - rifabutin capsules usp are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. rifabutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg - rifabutin capsules usp are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. rifabutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg

United States - English - NLM (National Library of Medicine)

novitium pharma llc - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin capsules are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. rifabutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals, inc. - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin capsules are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. rifabutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg - mycobutin capsules are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. mycobutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg - mycobutin capsules are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. mycobutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

United States - English - NLM (National Library of Medicine)

department of state health services, pharmacy branch - rifabutin (unii: 1w306tda6s) (rifabutin - unii:1w306tda6s) - rifabutin 150 mg - mycobutin capsules are indicated for the prevention of disseminated mycobacterium avium complex (mac) disease in patients with advanced hiv infection. mycobutin capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - rifabutin - capsules - rifabutin 150 mg - rifabutin - rifabutin - for the treatment of chronic tuberculosis where there is evidence of acid fast bacteria resistant to rifampicin or to two other alternative drugs. for the treatment of infections caused by mac or other atypical mycobacteria where there is evidence of resistant bacteria as above. for the treatment of infections caused by mac or other atypical mycobacteria in aids patients in all cases not subject to the above restrictions. for prevention of mac infections in aids patients whose cd4 counts lower or eqval to 200/mm3